Close

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more

Shire news

17 Dec 2008 Director/PDMR Shareholding (16KB PDF)
01 Dec 2008 Total Voting Rights
25 Nov 2008 Block Listing Six Monthly Return (23KB PDF)
25 Nov 2008 Director/PDMR Shareholding (16KB PDF)
18 Nov 2008 Investor seminar (31KB PDF)
12 Nov 2008 Confirmation of HGT business day - 18th November 2008 (19KB PDF)
07 Nov 2008 Director/PDMR Shareholding (16KB PDF)
05 Nov 2008 Shire successfully settles former TKT shareholder appraisal rights litigation (20KB PDF)
04 Nov 2008 Directors/PDMR Shareholding
03 Nov 2008 Total Voting Rights (16KB PDF)
29 Oct 2008 Shire’s new product portfolio delivers strong quarterly performance (280KB PDF)
15 Oct 2008 Third quarter 2008 results date notification – 29 October 2008 (17KB PDF)
01 Oct 2008 CHANGE OF NAME TO SHIRE PLC (17KB PDF)
01 Oct 2008 Total Voting Rights (18KB PDF)
25 Sep 2008 Correction - Results of the Annual General Meeting held on September 24, 2008 (22KB PDF)
24 Sep 2008 Results of the Annual General Meeting held on September 24, 2008 (21KB PDF)
23 Sep 2008 Director/PDMR Shareholding (18KB PDF)
12 Sep 2008 Notification of Acquisition of American Depository Shares by Persons Discharging Managerial Responsibilities
08 Sep 2008 Notification of major interests in shares (36KB PDF)
01 Sep 2008 Total Voting Rights (18KB PDF)
01 Sep 2008 Elections for interim dividend in respect of the half year for the six months ended June, 30 2008 (20KB PDF)
01 Sep 2008 Notification of Acquisition of American Depository Shares by Persons Discharging Managerial Responsibilities (18KB PDF)
22 Aug 2008 Notice of the 2008 Annual General Meeting and Proxy Card (18KB PDF)
13 Aug 2008 SHIRE ANNOUNCES HOLDING OF 81% IN JERINI AG AND PUBLICATION OF OFFER DOCUMENT (23KB PDF)
07 Aug 2008 Half Yearly Report (370KB PDF)
06 Aug 2008 Notification of Acquisition of Shares by Director/Person Discharging Managerial Responsibilities (18KB PDF)
06 Aug 2008 Director/PDMR Shareholding (19KB PDF)
04 Aug 2008 Notification of Acquisition of American Depository Shares by a Director/Person Discharging Managerial Responsibilities (18KB PDF)
04 Aug 2008 Director/PDMR Shareholding (20KB PDF)
04 Aug 2008 Notification of Acquisition of American Depository Shares by a Director/Person Discharging Managerial Responsibilities (19KB PDF)
01 Aug 2008 CNBC interview with Angus Russell following Shire's Q2 results 2008
31 Jul 2008 Shire delivers strong quarter: driven by $243m of new product sales (+164% YOY growth). Revenue guidance upgraded. (282KB PDF)
30 Jul 2008 Tatjana May appointed Chair of Shire’s Corporate Responsibility Committee
23 Jul 2008 Shire Appoints Dr. Jeffrey Jonas Senior Vice President, R&D, Specialty Pharmaceuticals
21 Jul 2008 Robin Buchanan to step down as non-executive director on completion of term of office
15 Jul 2008 Jerini Receives European Commission Approval for FIRAZYR® (Icatibant) in the Treatment of HAE (51KB PDF)
04 Jul 2008 Second quarter 2008 results date notification - 31 July 2008 (21KB PDF)
03 Jul 2008 Shire erweitert HGT-Portfolio mit neuem Orphan-Arznei-mittel – Einführung in der EU steht unmittelbar bevor (54KB PDF)
03 Jul 2008 Shire to add new orphan drug to its HGT portfolio – EU launch imminent (52KB PDF)
19 Jun 2008 Director/PDMR Shareholding (21KB PDF)
16 Jun 2008 Notification of Acquisition of American Depository Shares by Person Discharging Managerial Responsibilities (19KB PDF)
10 Jun 2008 Graham Hetherington appointed Chief Financial Officer and Board Director at Shire (32KB PDF)
27 May 2008 Shire Announces Approval of ELAPRASE® (idursulfase) in Brazil (63KB PDF)
23 May 2008 Application for Listing of Shire Limited Ordinary Shares (31KB PDF)
22 May 2008 Court Approves Scheme of Arrangement (45KB PDF)
20 May 2008 Annual Information Update (24KB PDF)
09 May 2008 Results of Court Meeting and Extraordinary General Meeting - Shareholders Approve Scheme of Arrangement and New Share Plans (31KB PDF)
09 May 2008 Shire opens new office in Norway
01 May 2008 Shire welcomes the Court of Appeal's decision that NICE review of Alzheimer's drugs was procedurally unfair (17KB PDF)
28 Apr 2008 Publication of Supplementary Prospectus (30KB PDF)
25 Apr 2008 Following a good start to the year Shire reaffirms full year 2008 financial guidance (274KB PDF)
24 Apr 2008 Dr Michael Rosenblatt appointed Non-Executive Director at Shire (29KB PDF)
24 Apr 2008 Shire enhances its orphan drug pipeline with the acquisition of a new clinical candidate for Metachromatic Leukodystrophy (33KB PDF)
23 Apr 2008 FDA Approves VYVANSE (TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults (38KB PDF)
16 Apr 2008 New Shire Holding Company Proposal
16 Apr 2008 First Quarter 2008 Results Date Notification (18KB PDF)
15 Apr 2008 SHIRE TO INTRODUCE A NEW UK LISTED HOLDING COMPANY (135KB PDF)
04 Apr 2008 Annual Report and Accounts for the year ended December 31, 2007 (18KB PDF)
02 Apr 2008 Movement of shares out of the Employee Benefit Trust (89KB PDF)
31 Mar 2008 Director/PDMR Shareholding (21KB PDF)
25 Mar 2008 IFRS results for the year ending December 31, 2007 (263KB PDF)
03 Mar 2008 RENOVO ANNNOUNCES JUVISTA® PHASE 2 TRIAL RESULTS IN SCAR REVISION AND BREAST AUGMENTATION SURGERY (95KB PDF)
03 Mar 2008 Renovo announces results of latest Phase 2 studies of JUVISTA(R) (human recombinant TGF Beta 3) (107KB PDF)
27 Feb 2008 Growing Support for World Kidney Day
26 Feb 2008 Notification of Acquisition of American Depository Shares by Persons Discharging Managerial Responsibilities (19KB PDF)
25 Feb 2008 Director/PDMR Shareholding (22KB PDF)
21 Feb 2008 CNBC interview with Matthew Emmens, CEO, following Shire’s full year 2007 results (video)
21 Feb 2008 Q4, YEAR 2007 RESULTS (301KB PDF)
20 Feb 2008 Correction (64KB PDF)
19 Feb 2008 Healthcare Businesswomen’s Association Announces 2008 Woman of the Year, Charlotte Sibley, Senior Vice President, Leadership Development, Shire Pharmaceuticals (29KB PDF)
14 Feb 2008 Shire HGT Announces Commitment to Continue Expansion in Massachusetts (28KB PDF)
13 Feb 2008 Shire’s ELAPRASE® (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome (49KB PDF)
12 Feb 2008 Full Year 2007 results date notification – 21 February 2008 (35KB PDF)
17 Jan 2008 Shire Completes Fosrenol® Roll-Out in Major European Markets With Launch in Spain (81KB PDF)

Did you know...

We have developed a
version of this web site
that is suitable for your
portable device
.